The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer
Abstract
The American Society of Colon and Rectal Surgeons (ASCRS) is dedicated to ensuring high-quality patient care by advancing the science, prevention, and management of disorders and diseases of the colon, rectum, and anus. The Clinical Practice Guidelines Committee is composed of society members who are chosen because they have demonstrated expertise in the specialty of colon and rectal surgery. This committee was created to lead international efforts in defining quality care for conditions related to the colon, rectum, and anus and develop clinical practice guidelines based on the best available evidence. While not proscriptive, these guidelines provide information on which decisions can be made and do not dictate a specific form of treatment. These guidelines are intended for the use of all practitioners, health care workers, and patients who desire information about the management of the conditions addressed by the topics covered in these guidelines. These guidelines should not be deemed inclusive of all proper methods of care nor exclusive of methods of care reasonably directed toward obtaining the same results. The ultimate judgment regarding the propriety of any specific procedure must be made by the physician in light of all the circumstances presented by the individual patient. STATEMENT OF THE PROBLEM The American Cancer Society estimated that roughly 105,000 Americans would be diagnosed with colon cancer and 43,000 with rectal cancer, and that 53,200 deaths would be attributed to these cancers in the year 2020.1 In the United States, colorectal cancer remains the third most common cancer and the third most common cause of cancer-related death.2 Approximately nine of 10 patients with colorectal cancer are diagnosed at 50 years of age or older. While the incidence and mortality rate of colorectal cancer are declining for individuals older than 50 years of age, both are on the rise for those younger than 50.1 The treatment of patients with colon cancer is largely guided by the stage at presentation, emphasizing the importance of a comprehensive strategy for diagnosis, evaluation, and treatment. Surgery is the primary treatment for most patients with colon cancer, while chemotherapy is used most commonly in the adjuvant setting. In the United States cohort of the international CONCORD-2 study, five-year net (cancer-specific) survival was 90%, 70%, and 14% among those with localized, regional, or distant distribution of their colon cancer, respectively.3 Colorectal cancer screening, bowel preparation, hereditary colon cancer, enhanced recovery pathways, surveillance and survivorship after curative treatment, and prevention of thromboembolic disease, while relevant to the management of patients with colon cancer, are beyond the scope of these guidelines and are addressed in other American Society of Colon and Rectal Surgeons (ASCRS) guidelines.4–9 METHODS This guideline is based on the previous colon cancer parameter published in 2017.10 Compared with 2017, this guideline has 11 new, 10 updated, and 2 excluded recommendations (Table 1). The literature searches were performed with PubMed using a combination of specialty-specific journal titles (Appendix 1, Supplemental Digital Content 1, https://links.lww.com/DCR/B798) organized under the subject headings of Gastroenterology, Imaging, Oncology and General Medicine, and Surgery, and the Medline Subject Heading (MeSH) “colorectal neoplasm” combined with the search limits of “journal article” or “guideline” or “controlled clinical trial” or “clinical trial” or “clinical study” or “meta-analysis” or “multicenter study” or “observational study” or “practice guideline” or “randomized controlled trial” or “systematic review,” and the additional search limits of human studies, English language, and adults, and were limited to citations included in searches limited to the date range of April 8, 2015, to April 4, 2021. Additional subject-specific searches were performed with the PubMed search terms/phrases: 1) “incomplete colonoscopy” and 2) “conversion AND colorectal AND liver,” both limited to English language, journal article, and date range of August 6, 2015, to April 4, 2021, and 3) “Oncotype DX OR coloprint OR ColDx OR ctDNA OR circulating tumor DNA AND colon cancer,” limited to English language and journal article, with a date range of January 1, 2009, to June 27, 2021. An Embase query, inclusive of publication years 2017 to 2020, completed on December 2, 2020, with exclusion of titles also included in Medline/PubMed, resulted in 241 unique titles that were screened and resulted in the inclusion of 10 additional titles for the qualitative synthesis phase of the literature review. An additional 35 titles were identified from embedded references. These searches yielded a total of 7958 unique citations. A professional medical librarian provided consultation for the literature searches. The citations were then reviewed by the authors who selected the citations tha
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Colorectal cancer statistics, 2020
Siegel, R. L., Miller, K. D., Goding Sauer, A., Fedewa, S. A., Butterly, L. F., Anderson, J. C., Cercek, A., Smith, R. A., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21601 · Cited by 4,880
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa032651 · Cited by 3,395
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
André, T., Shiu, K.-K., Kim, T. W., Jensen, B. V., Jensen, L. H., Punt, C., Smith, D., Garcia-Carbonero, R., Benavides, M., Gibbs, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2017699 · Cited by 3,099
Overman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H.-J., Morse, M. A., Desai, J., Hill, A., Axelson, M., Moss, R. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30422-9 · Cited by 2,836
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
Lacy, A. M., García-Valdecasas, J. C., Delgado, S., Castells, A., Taurá, P., Piqué, J. M., & Visa, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09290-5 · Cited by 2,441
Cited by
Nawras, M., Chawla, K., DeRiso, A., Dubchuk, C., Beran, A., Aziz, M., & Pannell, S. M. (2023) · International Journal of Colorectal Disease · doi:10.1007/s00384-023-04466-x · Cited by 3
Metadata
- Authors
- Vogel, J. D., Felder, S. I., Bhama, A. R., Hawkins, A. T., Langenfeld, S. J., Shaffer, V. O., Thorsen, A. J., Weiser, M. R., Chang, G. J., Lightner, A. L., Feingold, D. L., & Paquette, I. M.
- Venue
- Diseases of the Colon & Rectum
- Published
- 2022-01-18
- Volume
- 65
- Issue
- 2
- Pages
- 148-177
- ISSN
- 0012-3706 (ISSN-L)
- OpenAlex
- W3211775721
- Cited by
- 401
- References
- 202
- FWCI
- 16.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer. https://app.cochat.ai/papers/10.1097/dcr.0000000000002323
- The paper
- Vogel, J. D., Felder, S. I., Bhama, A. R., Hawkins, A. T., Langenfeld, S. J., Shaffer, V. O., Thorsen, A. J., Weiser, M. R., Chang, G. J., Lightner, A. L., Feingold, D. L., & Paquette, I. M. (2022). The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer. Diseases of the Colon & Rectum. https://doi.org/10.1097/dcr.0000000000002323
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.